MDR is being priced as MedAdvisor and not MedAdvisor with Adheris.
Anyone buying before the June quarter results is extremely brave.
There's a number of announcements to get through that might steady the ship:
- Replacement CEO. They are targeting a US based Exec.
- What calibre resource will they get to manage an ASX listed healthcare stock?
- Final earn-out to Syneos in September.
- How will this be funded? Cash, CR, PFG?
Better numbers in June is needed, else they will require a number of quarters to regain trust.
- Any and I mean any price sensitive news that confirms an extension to or new revenue stream.
- It's all well and good to simply publish quarterlies, if you're meeting your revenue targets.
- Forums
- ASX - By Stock
- MDR
- Ann: Quarterly Report and Appendix 4C
MDR
medadvisor limited
Add to My Watchlist
1.54%
!
6.4¢

Ann: Quarterly Report and Appendix 4C, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.4¢ |
Change
-0.001(1.54%) |
Mkt cap ! $40.01M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.3¢ | $25.77K | 400.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35556 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 73171 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35556 | 0.063 |
1 | 8064 | 0.062 |
1 | 100000 | 0.061 |
2 | 40000 | 0.060 |
1 | 8500 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 73171 | 1 |
0.066 | 190000 | 1 |
0.079 | 120000 | 1 |
0.080 | 77312 | 3 |
0.081 | 10331 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |